title: Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
abstract: Sera from 114 first-degree relatives of insulin-dependent diabetes mellitus (type I diabetes) patients and 81 healthy individuals living in Germany were analyzed for antibodies to rat brain glutamic acid decarboxylase (GAD-ab) using an immunoprecipitation assay. The determination of GAD-ab in the 81 islet cell antibody (ICA) and insulin autoantibody (IAA) negative healthy individuals established a normal range (mean +/- 2 SD); 2 healthy individuals (2.5%) possessed GAD-ab levels above this range, but became negative on follow-up. None of 86 ICA-/IAA- first-degree relatives had GAD-ab; whereas, 42.9% of 28 ICA+ and/or IAA+ relatives were positive for GAD-ab. Presence of GAD-ab was negatively correlated with IAA (P = 0.02) and positively with ICA (P = 0.0006). Follow-up samples were obtained from 25 of 28 ICA+ and/or IAA+ relatives with a mean (+/- SD) follow-up period of 20.6 +/- 12.1 months. In these 25 relatives, GAD-ab were positive in 70% ICA+/IAA-, 0% ICA-/IAA+, and 57.1% ICA+/IAA+ relatives in the first sample and in 57.1% ICA+/IAA-, 0% ICA-/IAA+, and 70% ICA+/IAA+ relatives in the last sample. GAD-ab, once detected, persisted in 9 of 11 GAD-ab+ relatives. Of the relatives, 2 converted to GAD-positivity, concomitant with the appearance of ICA, and 2 others lost GAD-ab during follow-up. Of the 28 ICA+ and/or IAA+ relatives, 6 progressed to overt type I diabetes on follow-up, and GAD-ab were detectable in 4 of these relatives.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Diabetes Research Institute, Schwabing-City-Hospital, Munich, Germany.
authors.forename: U
authors.initials: U
authors.lastname: Roll
authors.forename: M R
authors.initials: MR
authors.lastname: Christie
authors.forename: E
authors.initials: E
authors.lastname: Standl
authors.forename: A G
authors.initials: AG
authors.lastname: Ziegler
mesh_terms: D000293:Adolescent; D000328:Adult; D000375:Aging / Q000276:immunology; D000818:Animals; D000906:Antibodies / Q000097:blood*; D001323:Autoantibodies / Q000097:blood*; D001921:Brain / Q000201:enzymology; D002648:Child; D002675:Child, Preschool; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000235:genetics* / Q000276:immunology*; D005260:Female; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D005968:Glutamate Decarboxylase / Q000276:immunology* / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D007515:Islets of Langerhans / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009679:Nuclear Family; D051381:Rats; D017208:Rats, Wistar; D012016:Reference Values
chemical_list: D000906:Antibodies; D001323:Autoantibodies; C024211:islet cell antibody; D005968:Glutamate Decarboxylase